| Literature DB >> 32378340 |
Tommi Ojanen1, Heikki Kyröläinen2,3, Elena Kozharskaya2, Keijo Häkkinen2.
Abstract
The purpose of this study was to investigate the effects of two different training programs on strength and power performance and serum hormone concentrations. A total of 104 male soldiers volunteered and took part in the 12-week training period with baseline, mid-, and post-measurements of body composition, muscle strength, lower and upper body power, and blood samples to determine serum hormone concentrations. The mean (±SD) age of subjects was 20 ± 1 years, height 180 ± 6 cm and body mass 72.4 ± 8.8 kg. The subjects were divided into three different training groups: soldier task-specific training (TS), strength training (ST), and control (CON). Each group had a total of 18 training sessions during the 12-week study. In the muscle strength tests, most improvements could be observed in the TS and ST groups, especially, during the first weeks of the training period. Maximal isometric leg extension force increased significantly by 7.9 ± 12.2% (p < .05) in the TS and 7.1 ± 12.6% (p < .05) in the ST groups between the PRE and MID, as well as between the PRE and POST measurements by 8.1 ± 12.4% (p < .05) in TS and 12.3 ± 15.3% (p < .01) in ST. Serum TES concentration increased significantly in TS between the PRE and MID (16.8 ± 33.9%) and PRE and POST (11.2 ± 16.7%) measurements. Serum COR concentrations decreased in TS between the MID and POST (-7.8 ± 10.9%) and PRE and POST (-11.0 ± 14.3%) measurements. Although the differences observed were rather minor in magnitude, training in the TS and ST groups led to greater improvements in muscle strength and power performance compared to the training in the CON group. The development of strength and/or power of the lower and upper body was greater in the TS and ST groups, which is crucial for warfighter's performance. Therefore, it is important to have a structured resistance-training program during military training to optimize the strength, power, and military-specific performance.Entities:
Keywords: Physical training; hormonal; power; soldiers; strength
Mesh:
Substances:
Year: 2020 PMID: 32378340 PMCID: PMC7202986 DOI: 10.14814/phy2.14422
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Mean (±SD) age, height, body mass, and BMI in the study groups
| Variable | Task specific | Strength | Control |
|---|---|---|---|
| ( | ( | ( | |
| Age (yrs.) | 19.5 (0.8) | 19.5 (0.7) | 19.6 (0.8) |
| Height (cm) | 180.1 (6.6) | 181.5 (6.0) | 179.5 (5.4) |
| Body mass (kg) | 74.6 (10.4) | 72.3 (7.5) | 70.3 (10.2) |
| BMI (kg·m−2) | 23.0 (2.2) | 22.0 (1.7) | 22.4 (2.9) |
Abbreviation: BMI, body mass index.
Design of the training protocols in the study groups
| Session | Task‐specific group | Strength group | Control group | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | |
| Week 1 | PRE tests | PRE tests | PRE tests | ||||||
| Week 2 | 2x3x6s | 2x3x30s | 3x6s; 3x30s | 4x3x15x10−30% | 4x3x15x10−30% | 4x3x10x40−60% | Military PE | Military PE | Military PE |
| Week 3 | 2x4x6s | 2x4x30s | 4x6s; 4x30s | 4x3x10x40−60% | BWT x 5 exercises | BWT x 5 exercises | Military PE | Military PE | Military PE |
| Week 4 | 3x3x6s | 3x3x45s | 4x6s; 4x45s | 6x3x6x20−40% | 4x3x3−5x70−90% | 4x3x8x50−75% | Military PE | Military PE | Military PE |
| Week 5 | 3x3x6s | 3x3x45s | 4x6s; 4x45s | 6x3x6x20−40% | 4x3x3−5x70−90% | 4x3x12x50−75% | Military PE | Military PE | Military PE |
| Week 6 | Military field training | Military field training | Military field training | ||||||
| Week 7 | MID tests | MID TESTS | MID tests | ||||||
| Week 8 | 3x3x6s | 4x45s | 3x3x60s | BWT x 5 exercises | BWT x 5 exercises | 4x3x3−5x70−90% | Military PE | Military PE | Military PE |
| Week 9 | Military field training | Military field training | Military field training | ||||||
| Week 10 | 3x4x6s | 3x6s; 3x60s | 3x4x6s | 5x3x4−6x70−90% | 6x3x4−6x20−40% | 5x2x4−6x70−90% | Military PE | Military PE | Military PE |
| Week 11 | Military field training | Military field training | Military field training | ||||||
| Week 12 | POST tests | POST tests | POST tests | ||||||
Mean (±SD) values of body composition in the study groups
| Group | PRE | MID | POST | |Effect size| | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean (± | 95% CI | Mean (± | 95% CI | Mean (± | 95% CI | 1 versus 2 | 2 versus 3 | 1 versus 3 | ||
| BM (kg) | TS | 74.6 ± 10.4 | 69.6; 79.6 | 74.3 ± 9.7 | 69.7; 79.0 | 74.8 ± 9.4 | 70.2; 79.3 | 0.03 | 0.05 | 0.02 |
| ST | 72.3 ± 7.7 | 68.5; 76.0 | 72.7 ± 7.5 | 69.1; 76.3 | 73.3 ± 7.9 #, § | 69.5; 77.1 | 0.05 | 0.08 | 0.13 | |
| CON | 70.3 ± 10.2 | 63.8; 76.7 | 69.8 ± 9.0 | 64.1; 75,5 | 70.1 ± 8.3 | 64.8; 75.3 | 0.05 | 0.03 | 0.02 | |
| SMM (kg) | TS | 36.7 ± 4.8 | 34.4; 39.0 | 37.3 ± 4.7* | 35.0; 39.6 | 37.1 ± 4.8# | 34.8; 39.4 | 0.12 | 0.04 | 0.08 |
| ST | 37.0 ± 4.1 | 35.1; 38.9 | 37.4 ± 4.0* | 35.5; 39.3 | 37.5 ± 4.1 | 35.5; 39.4 | 0.10 | 0.02 | 0.12 | |
| CON | 34.7 ± 4.3 | 31.9; 37.4 | 34.8 ± 4.4 | 32.0; 37.5 | 34.8 ± 4.5 | 31.9; 37.6 | 0.02 | 0.00 | 0.02 | |
| FM (kg) | TS | 10.1 ± 4.6 | 7.9; 12.2 | 8.9 ± 3.7* | 7.1; 10.7 | 9.7 ± 3.7§§ | 7.9; 11.5 | 0.28 | 0.21 | 0.09 |
| ST | 7.3 ± 2.8 | 6.0; 8.6 | 7.2 ± 2.9 | 5.9; 8.6 | 7.9 ± 3.1§§§ | 6.4; 9.3 | 0.03 | 0.23 | 0.20 | |
| CON | 9.2 ± 5.1 | 6.0; 12.4 | 8.7 ± 4.3 | 6.0; 11.4 | 8.9 ± 3.7 | 6.6; 11.3 | 0.10 | 0.05 | 0.07 | |
| FAT% | TS | 13.3 ± 4.7 | 11.0; 15.5 | 11.9 ± 3.9* | 10.0; 13.8 | 12.9 ± 4.1§§ | 10.9; 14.9 | 0.32 | 0.24 | 0.09 |
| ST | 10.1 ± 3.5 | 8.4; 11.7 | 9.9 ± 3.5 | 8.2; 11.5 | 10.6 ± 3.6§§§ | 8.9; 12.3 | 0.06 | 0.19 | 0.14 | |
| CON | 12.6 ± 5.7 | 9.0; 16.3 | 12.3 ± 5.4 | 8.9; 15.7 | 12.7 ± 4.6 | 9.7; 15.6 | 0.05 | 0.08 | 0.02 | |
Abbreviations: BM, body mass; CON, control; FAT%, fat percentage; FM, fat mass; SMM, skeletal muscle mass; ST, strength; TS, task‐specific. * = PRE to MID values *=p < .05; # = PRE to POST values, #=p < .05, MID to POST values §= p < .05, §§=p < .01, §§§<0.001.
Mean (±SD) strength and power performance values in the study groups
| Group | PRE | MID | POST | |Effect size| | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean (± | 95% CI | Mean (± | 95% CI | Mean (± | 95% CI | 1 versus 2 | 2 versus 3 | 1 versus 3 | ||
| CMJ (cm) | TS | 30 ± 5 | 27; 32 | 29 ± 5 | 27; 31 | 31 ± 4**, ### | 29; 33 | 0.20 | 0.43 | 0.22 |
| ST | 32 ± 6 | 29; 35 | 33 ± 5 | 30; 35 | 34 ± 5 | 32; 36 | 0.18 | 0.20 | 0.35 | |
| CON | 31 ± 6 | 28; 35 | 30 ± 7* | 25; 34 | 31 ± 6 | 28; 35 | 0.15 | 0.15 | 0.00 | |
| Power Max (w) | TS | 1,038 ± 153 | 964; 1,112 | 1,075 ± 152* | 1,002; 1,149 | 1,096 ± 141*, ## | 1,028; 1,164 | 0.24 | 0.14 | 0.39 |
| ST | 1,070 ± 112 | 1,012; 1,119 | 1,119 ± 120** | 1,054; 1,159 | 1,120 ± 126** | 1,051; 1,165 | 0.41 | 0.01 | 0.41 | |
| CON | 952 ± 104 | 896; 1,040 | 992 ± 136 | 905; 1,078 | 1,017 ± 139** | 928; 1,105 | 0.32 | 0.18 | 0.51 | |
| Upper body strength (kg) | TS | 79 ± 16 | 71; 86 | 77 ± 14 | 70; 83 | 80 ± 13### | 74; 87 | 0.13 | 0.22 | 0.07 |
| ST | 77 ± 15 | 70; 84 | 82 ± 16** | 72; 88 | 82 ± 17** | 74; 90 | 0.32 | 0.00 | 0.31 | |
| CON | 72 ± 15 | 64; 83 | 73 ± 12 | 70; 83 | 76 ± 15 | 65; 86 | 0.07 | 0.21 | 0.26 | |
| Lower body strength (kg) | TS | 240 ± 46 | 219; 263 | 255 ± 49* | 232; 279 | 263 ± 48** | 240; 286 | 0.32 | 0.16 | 0.48 |
| ST | 227 ± 46 | 205; 248 | 240 ± 37* | 222; 257 | 240 ± 38* | 222; 258 | 0.31 | 0.00 | 0.30 | |
| CON | 214 ± 51 | 182; 247 | 220 ± 61 μ | 181; 259 | 222 ± 60 μ | 184; 261 | 0.10 | 0.03 | 0.14 | |
| Standing long jump (cm) | TS | 216 ± 25 | 204; 228 | 215 ± 21 | 205; 225 | 216 ± 21 | 205; 226 | 0.04 | 0.05 | 0.00 |
| ST | 228 ± 17 | 220; 237 | 228 ± 18 | 218; 233 | 229 ± 17 | 220; 235 | 0.00 | 0.06 | 0.06 | |
| CON | 214 ± 32 | 194; 234 | 210 ± 28 | 192; 228 | 210 ± 31μ | 190; 229 | 0.13 | 0.00 | 0.12 | |
| Sit‐ups (reps/min) | TS | 41 ± 10 | 36; 45 | 42 ± 9 | 37; 46 | 40 ± 12 | 34; 46 | 0.10 | 0.18 | 0.09 |
| ST | 44 ± 9 | 39; 48 | 45 ± 8 | 40; 48 | 45 ± 9 | 40; 48 | 0.12 | 0.00 | 0.11 | |
| CON | 41 ± 7 | 36; 46 | 43 ± 8 | 38; 48 | 42 ± 7 | 37; 47 | 0.26 | 0.13 | 0.14 | |
| Push‐Ups (reps/min) | TS | 34 ± 13 | 28; 40 | 40 ± 14** | 33; 47 | 38 ± 15 | 31; 45 | 0.43 | 0.13 | 0.28 |
| ST | 38 ± 12 | 32; 44 | 43 ± 13* | 36; 48 | 41 ± 14 | 34; 47 | 0.39 | 0.23 | 0.15 | |
| CON | 35 ± 14 | 25; 45 | 41 ± 15 | 29; 50 | 44 ± 16** | 33; 54 | 0.40 | 0.19 | 0.58 | |
Abbreviations: CMJ, counter measurement jump; CON, control; Lower body strength in maximal isometric action; Power ave, average 6 s power cycling; Power max, maximal 6 s power cycling; ST, strength; TS, task‐specific; Upper body strength in maximal isometric action. * = PRE to MID values *=p < .05; # = PRE to POST values, #=p < .05, ##=p < .01, ###<0.001, MID to POST values §= p < .05, §§=p < .01, §§§<0.001; between the groups, μ = p<.05.
Figure 1Mean (±SD) serum hormonal concentrations in the groups. COR, cortisol; CON, control; IGF‐1 insulin‐like growth factor 1; IGFBP‐3, insulin‐like growth factor binding protein 3; SHBG, sex‐hormone binding globulin; ST, strength; TES, testosterone; TES/COR, testosterone – cortisol ratio; TES/SHBG, testosterone – sex‐hormone binding globulin; TS, task specific. Within the groups; #=p < .05, ##=p < .01, ###=p < .001, compared to PRE value; §=p < .05, compared to MID value.